These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38417442)

  • 61. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
    Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Foxp3
    Kohno M; Murakami J; Wu L; Chan ML; Yun Z; Cho BCJ; de Perrot M
    J Immunol; 2020 Nov; 205(9):2519-2531. PubMed ID: 32948683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
    Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
    Front Immunol; 2021; 12():705378. PubMed ID: 34526987
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.
    Beauford SS; Kumari A; Garnett-Benson C
    BMC Immunol; 2020 Apr; 21(1):18. PubMed ID: 32299365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CTLA-4 expressed by FOXP3
    Klocke K; Holmdahl R; Wing K
    Immunology; 2017 Sep; 152(1):125-137. PubMed ID: 28497863
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells.
    Kim MJ; Kim K; Park HJ; Kim GR; Hong KH; Oh JH; Son J; Park DJ; Kim D; Choi JM; Lee I; Ha SJ
    Nat Immunol; 2023 Jan; 24(1):148-161. PubMed ID: 36577929
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells.
    Sugita S; Horie S; Nakamura O; Futagami Y; Takase H; Keino H; Aburatani H; Katunuma N; Ishidoh K; Yamamoto Y; Mochizuki M
    J Immunol; 2008 Dec; 181(11):7525-36. PubMed ID: 19017942
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
    Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
    Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes.
    Jebbawi F; Fayyad-Kazan H; Merimi M; Lewalle P; Verougstraete JC; Leo O; Romero P; Burny A; Badran B; Martiat P; Rouas R
    J Transl Med; 2014 Aug; 12():218. PubMed ID: 25090912
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1.
    Han Y; Yang Y; Chen Z; Jiang Z; Gu Y; Liu Y; Xu S; Lin C; Pan Z; Zhou W; Cao X
    J Mol Med (Berl); 2014 May; 92(5):539-50. PubMed ID: 24668348
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel Effector Phenotype of Tim-3
    Liu Z; McMichael EL; Shayan G; Li J; Chen K; Srivastava R; Kane LP; Lu B; Ferris RL
    Clin Cancer Res; 2018 Sep; 24(18):4529-4538. PubMed ID: 29712685
    [No Abstract]   [Full Text] [Related]  

  • 76. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
    Yano H; Andrews LP; Workman CJ; Vignali DAA
    Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CD103 is a hallmark of tumor-infiltrating regulatory T cells.
    Anz D; Mueller W; Golic M; Kunz WG; Rapp M; Koelzer VH; Ellermeier J; Ellwart JW; Schnurr M; Bourquin C; Endres S
    Int J Cancer; 2011 Nov; 129(10):2417-26. PubMed ID: 21207371
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytotoxic T lymphocyte-associated protein 4 antibody aggrandizes antitumor immune response of oncolytic virus M1 via targeting regulatory T cells.
    Liu W; Liu Y; Hu C; Xu C; Chen J; Chen Y; Cai J; Yan G; Zhu W
    Int J Cancer; 2021 Sep; 149(6):1369-1384. PubMed ID: 34086978
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
    Hashemi V; Maleki LA; Esmaily M; Masjedi A; Ghalamfarsa G; Namdar A; Yousefi M; Yousefi B; Jadidi-Niaragh F
    Int Immunopharmacol; 2020 Jan; 78():106087. PubMed ID: 31841758
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8
    Semmrich M; Marchand JB; Fend L; Rehn M; Remy C; Holmkvist P; Silvestre N; Svensson C; Kleinpeter P; Deforges J; Junghus F; Cleary KL; Bodén M; Mårtensson L; Foloppe J; Teige I; Quéméneur E; Frendéus B
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35058324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.